Join for Free!
111306 members
table of contents table of contents

Investigated if carcinogen defense (phase 2) enzymes could be induced in the prostate …

Biology Articles » Biochemistry » Enzymology » Modest induction of phase 2 enzyme activity in the F-344 rat prostate » References

- Modest induction of phase 2 enzyme activity in the F-344 rat prostate

1.   Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005.
CA Cancer J Clin 2005, 55(1):10-30.
2.   Nelson WG, De Marzo AM, Isaacs WB: Prostate cancer.
N Engl J Med 2003, 349(4):366-381.
3.   Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, Nelson WG: Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
Proc Natl Acad Sci U S A 1994, 91(24):11733-11737.
4.   Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, Asgari K, Freije D, van Rees B, Gage WR, Bova GS, Isaacs WB, Brooks JD, DeWeese TL, De Marzo AM, Nelson WG: GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.
Am J Pathol 2001, 159(5):1815-1826.
5.   Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG: CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.
Cancer Epidemiol Biomarkers Prev 1998, 7(6):531-536.
6.   Nakayama M, Bennett CJ, Hicks JL, Epstein JI, Platz EA, Nelson WG, De Marzo AM: Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection.
Am J Pathol 2003, 163(3):923-933.
7.   Tsuchida S, Sato K: Glutathione transferases and cancer.
Crit Rev Biochem Mol Biol 1992, 27(4-5):337-384.
8.   Wattenberg LW: Inhibition of carcinogenesis by minor dietary constituents.
Cancer Res 1992, 52(7 Suppl):2085s-2091s.
9.   Kensler TW, Davidson NE, Groopman JD, Roebuck BD, Prochaska HJ, Talalay P: Chemoprotection by inducers of electrophile detoxication enzymes.
Basic Life Sci 1993, 61:127-136.
10.   Prochaska HJ, Santamaria AB, Talalay P: Rapid detection of inducers of enzymes that protect against carcinogens.
Proc Natl Acad Sci U S A 1992, 89(6):2394-2398.
11.   Spencer SR, Wilczak CA, Talalay P: Induction of glutathione transferases and NAD(P)H:quinone reductase by fumaric acid derivatives in rodent cells and tissues.
Cancer Res 1990, 50(24):7871-7875.
12.   Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y: Chemoprotection against cancer by phase 2 enzyme induction.
Toxicol Lett 1995, 82-83:173-179.
13.   Zhang Y, Kensler TW, Cho CG, Posner GH, Talalay P: Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates.
Proc Natl Acad Sci U S A 1994, 91(8):3147-3150.
14.   Meyer DJ, Harris JM, Gilmore KS, Coles B, Kensler TW, Ketterer B: Quantitation of tissue- and sex-specific induction of rat GSH transferase subunits by dietary 1,2-dithiole-3-thiones.
Carcinogenesis 1993, 14(4):567-572.
15.   Raza H, Mukhtar H: Differences in inducibility of cytochrome P-4501A1, monooxygenases and glutathione S-transferase in cutaneous and extracutaneous tissues after topical and parenteral administration of beta-naphthoflavone to rats.
Int J Biochem 1993, 25(10):1511-1516.
16.   van Lieshout EM, Peters WH, Jansen JB: Effect of oltipraz, alpha-tocopherol, beta-carotene and phenethylisothiocyanate on rat oesophageal, gastric, colonic and hepatic glutathione, glutathione S-transferase and peroxidase.
Carcinogenesis 1996, 17(7):1439-1445.
17.   De Long MJ, Prochaska HJ, Talalay P: Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols.
Cancer Res 1985, 45(2):546-551.
18.   Brooks JD, Goldberg MF, Nelson LA, Wu D, Nelson WG: Identification of potential prostate cancer preventive agents through induction of quinone reductase in vitro.
Cancer Epidemiol Biomarkers Prev 2002, 11(9):868-875.
19.   Brooks JD, Paton VG, Vidanes G: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane.
Cancer Epidemiol Biomarkers Prev 2001, 10(9):949-954.
20.   Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH: Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis.
Cancer Res 1991, 51(3):813-819.
21.   Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.
J Biol Chem 1974, 249(22):7130-7139.
22.   Prochaska HJ, Santamaria AB: Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers.
Anal Biochem 1988, 169(2):328-336.
23.   Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem 1976, 72:248-254.
24.   Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, Hasegawa R, Imaida K, Matsumoto K, Wakabayashi K, Sugimura T, Ito N: The prostate: a target for carcinogenicity of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods.
Cancer Res 1997, 57(2):195-198.
25.   Kensler TW: Chemoprevention by inducers of carcinogen detoxication enzymes.
Environ Health Perspect 1997, 105 Suppl 4:965-970.
26.   Matusheski NV, Jeffery EH: Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile.
J Agric Food Chem 2001, 49(12):5743-5749.
27.   Kassie F, Uhl M, Rabot S, Grasl-Kraupp B, Verkerk R, Kundi M, Chabicovsky M, Schulte-Hermann R, Knasmuller S: Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen.
Carcinogenesis 2003, 24(2):255-261.
28.   Cohen JH, Kristal AR, Stanford JL: Fruit and vegetable intakes and prostate cancer risk.
J Natl Cancer Inst 2000, 92(1):61-68.
29.   Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RSJ: Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study.
Cancer Epidemiol Biomarkers Prev 2000, 9(8):795-804.
30.   Kensler TW, Curphey TJ, Maxiutenko Y, Roebuck BD: Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins.
Drug Metabol Drug Interact 2000, 17(1-4):3-22.
31.   Camoirano A, Bagnasco M, Bennicelli C, Cartiglia C, Wang JB, Zhang BC, Zhu YR, Qian GS, Egner PA, Jacobson LP, Kensler TW, De Flora S: Oltipraz chemoprevention trial in qidong, people's republic of china: results of urine genotoxicity assays as related to smoking habits.
Cancer Epidemiol Biomarkers Prev 2001, 10(7):775-783.
32.   Dennis LK, Lynch CF, Torner JC: Epidemiologic association between prostatitis and prostate cancer.
Urology 2002, 60(1):78-83.
33.   Ripple MO, Henry WF, Rago RP, Wilding G: Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.
J Natl Cancer Inst 1997, 89(1):40-48.
34.   Ripple MO, Hagopian K, Oberley TD, Schatten H, Weindruch R: Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications.
Antioxid Redox Signal 1999, 1(1):71-81.
35.   Ripple MO, Henry WF, Schwarze SR, Wilding G, Weindruch R: Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA- binding activity in prostate carcinoma cells.
J Natl Cancer Inst 1999, 91(14):1227-1232.
36.   Malins DC, Polissar NL, Gunselman SJ: Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer.
Proc Natl Acad Sci U S A 1997, 94(1):259-264.
37.   Malins DC, Johnson PM, Wheeler TM, Barker EA, Polissar NL, Vinson MA: Age-related radical-induced DNA damage is linked to prostate cancer.
Cancer Res 2001, 61(16):6025-6028.
38.   Malins DC, Johnson PM, Barker EA, Polissar NL, Wheeler TM, Anderson KM: Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors.
Proc Natl Acad Sci U S A 2003, 100(9):5401-5406.
39.   Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J: Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.
Nat Genet 2002, 30(2):181-184.
40.   Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Chang B, Turner AR, Ewing CM, Wiley KE, Hawkins GA, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB: Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
Am J Hum Genet 2003, 72(1):208-212.
41.   Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH: Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.
Embo J 1997, 16(21):6355-6363.
42.   Clark LC, Combs GFJ, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JLJ, Park HK, Sanders BBJ, Smith CL, Taylor JR: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
JAMA 1996, 276(24):1957-1963.
43.   Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, Haapakoski J, Malila N, Rautalahti M, Ripatti S, Maenpaa H, Teerenhovi L, Koss L, Virolainen M, Edwards BK: Prostate cancer and supplementation with alpha-tocopherol and beta- carotene: incidence and mortality in a controlled trial.
J Natl Cancer Inst 1998, 90(6):440-446.
44.   Giovannucci E: Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature.
J Natl Cancer Inst 1999, 91(4):317-331.
45.   Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR: Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases.
Proc Natl Acad Sci U S A 1998, 95(9):5275-5280.
46.   de Braud F, Maffezzini M, Vitale V, Bruzzi P, Gatta G, Hendry WF, Sternberg CN: Bladder cancer.
Crit Rev Oncol Hematol 2002, 41(1):89-106.
47.   Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL: Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort.
J Natl Cancer Inst 1999, 91(7):605-613.
48.   Ye L, Dinkova-Kostova AT, Wade KL, Zhang Y, Shapiro TA, Talalay P: Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans.
Clin Chim Acta 2002, 316(1-2):43-53.
49.   Munday R, Munday CM: Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds.
J Agric Food Chem 2004, 52(7):1867-1871.
50.   Primiano T, Egner PA, Sutter TR, Kelloff GJ, Roebuck BD, Kensler TW: Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
Cancer Res 1995, 55(19):4319-4324.

rating: 0.00 from 0 votes | updated on: 18 May 2007 | views: 3782 |

Rate article: